STEMLINE THERAPEUTICS INC (STML) has 84 open-market insider trades by 9 insiders since 2013. The most active filer is Kenneth Hoberman, COO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Ivan Bergstein | CEO | — | 23 | $10.4M | 2020-06-10 |
| Kenneth Hoberman | COO | — | 29 | $9.4M | 2020-06-10 |
| David Gionco | CAO | — | 18 | $1.7M | 2020-06-10 |
| Eric K. Rowinsky | Chief Medical Officer | — | 4 | $647K | 2015-04-27 |
| Robert Francomano | Chief Commercial Officer | — | 4 | $72K | 2020-06-10 |
| Kenneth J. Zuerblis | Dir | — | 2 | $59K | 2020-06-10 |
| Ron Bentsur | Dir | — | 1 | $22K | 2020-06-10 |
| Alan S. Forman | Dir | — | 2 | $20K | 2020-06-10 |
| J. Kevin Buchi | Dir | — | 1 | $5K | 2015-06-23 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Robert Francomano | Chief Commercial Officer | Sell | $3K | 2020-05-04 |
| Ivan Bergstein | CEO | Sell | $523K | 2020-04-15 |
| David Gionco | CAO | Sell | $110K | 2020-04-01 |
| David Gionco | Chief Accounting Officer | Sell | $11K | 2020-03-16 |
| David Gionco | Chief Accounting Officer | Sell | $69K | 2020-03-09 |
| Robert Francomano | Chief Commercial Officer | Sell | $6K |
Companies that share insiders with STML, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2020-03-09 |
| Kenneth Hoberman | COO | Sell | $212K | 2020-03-09 |
| Ivan Bergstein | CEO | Sell | $572K | 2020-03-09 |
| Ivan Bergstein | CEO | Sell | $316K | 2020-02-25 |
| Kenneth Hoberman | COO | Sell | $148K | 2020-02-25 |
| David Gionco | CAO | Sell | $118K | 2020-02-25 |
| Robert Francomano | Chief Commercial Officer | Sell | $34K | 2020-02-07 |
| Kenneth Hoberman | COO | Sell | $311K | 2020-01-22 |
| Kenneth Hoberman | COO | Sell | $274K | 2020-01-08 |
| Ivan Bergstein | CEO | Sell | $987K | 2019-12-23 |